Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms
| Autor: | Eckhard Thiel, Martina Komor, Matthias B. Schulze, Olaf Hopfer, Ina Sabine Koehler, Wolf-Karsten Hofmann, Claudia Freitag, Dieter Hoelzer |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
DNA (Cytosine-5-)-Methyltransferase 1
Ineffective erythropoiesis Cancer Research DNA Repair Cellular differentiation DNMT3B Bisulfite sequencing Apoptosis Biology medicine.disease_cause DNA methyltransferase DNA Methyltransferase 3A hemic and lymphatic diseases medicine Humans Protein Isoforms Erythropoiesis DNA (Cytosine-5-)-Methyltransferases Promoter Regions Genetic Cells Cultured Cell Cycle Cell Differentiation Hematology Methylation DNA Methylation Hematopoietic Stem Cells Molecular biology Hematopoiesis Oncology Case-Control Studies Myelodysplastic Syndromes DNA methylation Cancer research |
| Zdroj: | Leukemia Research. 33:434-442 |
| ISSN: | 0145-2126 |
| DOI: | 10.1016/j.leukres.2008.08.014 |
| Popis: | Aberrant promoter methylation may contribute to the hematopoietic disturbances in myelodysplastic syndromes (MDS). To explore a possible mechanism, we therefore analyzed expression of DNA methyltransferase (DNMT) subtypes kinetics and aberrant promoter methylation of key regulatory genes during MDS hematopoiesis. An in vitro model of MDS lineage-specific hematopoiesis was generated by culturing CD34+ cells from healthy donors (n=7) and MDS patients (low-risk: RA/n=6, RARS/n=3; high-risk: RAEB/n=4, RAEB-T/n=2) with EPO, TPO and GCSF. Promoter methylation analysis of key genes involved in the control of apoptosis (p73, survivin, DAPK), DNA-repair (hMLH1), differentiation (RARb, WT1) and cell cycle control (p14, p15, p16, CHK2) was performed by methylation specific PCR of bisulfite-treated genomic DNA. Expression of DNMT1, DNMT3a and DNMT3b was analyzed and correlated with gene promoter methylation for each lineage at different time points. DNMT expression (all isoforms) was increased during thrombopoiesis whereas elevated DNMT1 level were seen during erythropoiesis. Associations between aberrant promoter methylation and DNMT expression were found in high-risk MDS for all lineages and during erythropoiesis. Hypermethylation of p15, p16, p73, survivin, CHK2, RARb and DAPK were associated with elevated DNMT isoform expression. No general overexpression of DNMT subtype was detected during MDS hematopoiesis. However a negative association of DNMT3a and 3b expression with MDS disease risk (IPSS) could be observed. Our data indicate that all mammalian DNMT isoforms may be involved in the aberrantly methylated phenotype in MDS but seem also to be essential for the differentiation of normal hematopoietic stem cells. In particular elevated DNMT1 expression may in particular contribute to ineffective erythropoiesis in MDS. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect